MedPath
Found 77 clinical trials|View Analysis
Sort by:

FebriDx® Method Comparison Study Protocol

Not yet recruiting
Conditions
Acute Respiratory Infections (ARIs)
First Posted Date
2024-12-24
Last Posted Date
2024-12-24
Lead Sponsor
Lumos Diagnostics
Target Recruit Count
800
Registration Number
NCT06746259
Locations
🇺🇸

Ascada Health, Fullerton, California, United States

🇺🇸

L&C Medical, Miami, Florida, United States

🇺🇸

Trujillo Medical Center, Miramar, Florida, United States

and more 3 locations

Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections

Not Applicable
Recruiting
Conditions
Antibiotic Prescribing for Acute Respiratory-tract Infections
First Posted Date
2024-08-23
Last Posted Date
2025-01-01
Lead Sponsor
Huazhong University of Science and Technology
Target Recruit Count
19424
Registration Number
NCT06568432
Locations
🇨🇳

40 Village Clinics, Xiantao, Hubei, China

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Phase 3
Recruiting
Conditions
Acute Respiratory Infection
Interventions
Drug: XC8
Drug: Placebo
First Posted Date
2024-04-23
Last Posted Date
2024-04-23
Lead Sponsor
Valenta Pharm JSC
Target Recruit Count
252
Registration Number
NCT06379542
Locations
🇷🇺

PiterKlinika LLC, Saint Petersburg, Russian Federation

🇷🇺

City Pediatric Outpatient Clinic number 5, Perm, Russian Federation

🇷🇺

ArsVite North-West, LLC, Saint Petersburg, Russian Federation

and more 3 locations

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Phase 4
Recruiting
Conditions
Acute Respiratory Infection
Common Cold
Influenza, Human
Interventions
Drug: Placebo
Drug: Ingavirin®
First Posted Date
2024-03-18
Last Posted Date
2024-04-01
Lead Sponsor
Valenta Pharm JSC
Target Recruit Count
80
Registration Number
NCT06315400
Locations
🇷🇺

GBOU VPO "Siberia State Medcial University" of Ministry of Health of Russian Federation, Tomsk, Russian Federation

🇷🇺

GBOU VPO "Rostov State Medical University" of Ministry of Health of Russian Federation, Rostov-na-Donu, Russian Federation

🇷🇺

GBOU VPO "Yaroslavl State Medical University" of Ministry of Health of Russian Federation, Yaroslavl, Russian Federation

A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe

Recruiting
Conditions
Acute Respiratory Tract Infection
First Posted Date
2024-02-28
Last Posted Date
2024-10-18
Lead Sponsor
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Target Recruit Count
2000
Registration Number
NCT06282718
Locations
🇧🇪

Universiteit Antwerpen, Antwerp, Belgium

🇫🇷

Centre Hospitalier Universitaire de Limoges, Limoges, France

🇬🇧

University of Oxford, Oxford, United Kingdom

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

Phase 3
Recruiting
Conditions
Influenza
Acute Respiratory Infection
Interventions
Drug: Cycloferon
Drug: Placebo
First Posted Date
2023-12-27
Last Posted Date
2024-02-05
Lead Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Target Recruit Count
578
Registration Number
NCT06183229
Locations
🇷🇺

City Outpatient Clinic #117, Saint-Petersburg, Russian Federation

🇷🇺

Research Center for Eco-safety, Ltd., Saint Petersburg, Russian Federation

Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

Not Applicable
Active, not recruiting
Conditions
Pneumonia
Acute Respiratory Tract Infections
Respiratory Syncytial Virus (RSV)
Interventions
Drug: 0.9% NaCl physiological saline
Combination Product: LiveSpo Navax
First Posted Date
2023-07-03
Last Posted Date
2024-08-05
Lead Sponsor
National Children's Hospital, Vietnam
Target Recruit Count
120
Registration Number
NCT05929599
Locations
🇻🇳

The Center for Pulmonology and Respiratory Care, Vietnam National Children's Hospital, Ha Noi, Vietnam

Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral Infections

Phase 2
Recruiting
Conditions
Acute Respiratory Infection
Interventions
Drug: TAZCOV
Drug: Vidicine
First Posted Date
2023-06-09
Last Posted Date
2023-06-09
Lead Sponsor
Makerere University
Target Recruit Count
510
Registration Number
NCT05897203
Locations
🇺🇬

Mulago National Referral Hospital, Kampala, Central, Uganda

POS-ARI-ER Observational Study of Acute Respiratory Infections

Not yet recruiting
Conditions
Acute Respiratory Infection
Acute Respiratory Tract Infection
First Posted Date
2023-04-14
Last Posted Date
2023-04-14
Lead Sponsor
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Target Recruit Count
11750
Registration Number
NCT05814237
Locations
🇧🇪

Erasme Hospital, Brussels, Belgium

🇭🇷

University Hospital for Infectious Diseases, Zagreb, Zagreb, Croatia

🇫🇷

CHU Grenoble, Grenoble, France

and more 20 locations

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

Completed
Conditions
Acute Respiratory Viral Infection
Interventions
Other: No Intervention
First Posted Date
2022-12-22
Last Posted Date
2024-12-10
Lead Sponsor
Janssen Research & Development, LLC
Target Recruit Count
140
Registration Number
NCT05661604
Locations
🇺🇸

Henry Ford Hospital, Detroit, Michigan, United States

🇨🇦

Hamilton Health Sciences, Hamilton, Ontario, Canada

🇺🇸

Fred Hutchinson Research Center, Seattle, Washington, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath